Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Effectiveness, safety, and local progression after percutaneous laser ablation for hepatocellular carcinoma nodules up to 4 cm are not affected by tumor location.

Francica G, Petrolati A, Di Stasio E, Pacella S, Stasi R, Pacella CM.

AJR Am J Roentgenol. 2012 Dec;199(6):1393-401. doi: 10.2214/AJR.11.7850.

PMID:
23169736
2.

Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.

Lencioni R, Cioni D, Crocetti L, Franchini C, Pina CD, Lera J, Bartolozzi C.

Radiology. 2005 Mar;234(3):961-7. Epub 2005 Jan 21.

PMID:
15665226
3.

[Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].

Wu J, Chen MH, Yang W, Wu W, Yan K.

Zhonghua Gan Zang Bing Za Zhi. 2012 Apr;20(4):256-60. doi: 10.3760/cma.j.issn.1007-3418.2012.04.006. Chinese.

PMID:
22964144
4.

Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations.

Wong SN, Lin CJ, Lin CC, Chen WT, Cua IH, Lin SM.

AJR Am J Roentgenol. 2008 Mar;190(3):W187-95. doi: 10.2214/AJR.07.2537.

PMID:
18287411
5.

Hepatocellular carcinoma with cirrhosis: are patients with neoplastic main portal vein invasion eligible for percutaneous radiofrequency ablation of both the nodule and the portal venous tumor thrombus?

Giorgio A, Di Sarno A, de Stefano G, Farella N, Scognamiglio U, de Stefano M, Giorgio V.

AJR Am J Roentgenol. 2009 Oct;193(4):948-54. doi: 10.2214/AJR.08.2087.

PMID:
19770315
6.

Radiofrequency ablation of hepatocellular carcinoma: can subcapsular tumors be safely ablated?

Kim YJ, Raman SS, Yu NC, Busuttil RW, Tong M, Lu DS.

AJR Am J Roentgenol. 2008 Apr;190(4):1029-34. doi: 10.2214/AJR.07.2293.

PMID:
18356451
7.

Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.

Zytoon AA, Ishii H, Murakami K, El-Kholy MR, Furuse J, El-Dorry A, El-Malah A.

Jpn J Clin Oncol. 2007 Sep;37(9):658-72. Epub 2007 Aug 31.

PMID:
17766723
8.

Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.

Takahashi S, Kudo M, Chung H, Inoue T, Ishikawa E, Kitai S, Tatsumi C, Ueda T, Minami Y, Ueshima K, Haji S.

Oncology. 2007;72 Suppl 1:98-103. Epub 2007 Dec 13.

PMID:
18087189
9.

Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations.

Teratani T, Yoshida H, Shiina S, Obi S, Sato S, Tateishi R, Mine N, Kondo Y, Kawabe T, Omata M.

Hepatology. 2006 May;43(5):1101-8.

PMID:
16628706
10.

Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone.

Kim JW, Kim JH, Won HJ, Shin YM, Yoon HK, Sung KB, Kim PN.

Eur J Radiol. 2012 Mar;81(3):e189-93. doi: 10.1016/j.ejrad.2011.01.122. Epub 2011 Feb 25.

PMID:
21353417
11.

Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?

Shibata T, Isoda H, Hirokawa Y, Arizono S, Shimada K, Togashi K.

Radiology. 2009 Sep;252(3):905-13. doi: 10.1148/radiol.2523081676. Epub 2009 Jun 30.

PMID:
19567647
12.

Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors.

Kim YS, Rhim H, Cho OK, Koh BH, Kim Y.

Eur J Radiol. 2006 Sep;59(3):432-41. Epub 2006 May 9.

PMID:
16690240
13.

Complications of laser ablation for hepatocellular carcinoma: a multicenter study.

Arienti V, Pretolani S, Pacella CM, Magnolfi F, Caspani B, Francica G, Megna AS, Regine R, Sponza M, Antico E, Di Lascio FM.

Radiology. 2008 Mar;246(3):947-55. doi: 10.1148/radiol.2463070390. Epub 2008 Jan 14.

PMID:
18195382
14.

Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.

Okuwaki Y, Nakazawa T, Kokubu S, Hidaka H, Tanaka Y, Takada J, Watanabe M, Shibuya A, Minamino T, Saigenji K.

Am J Gastroenterol. 2009 Nov;104(11):2747-53. doi: 10.1038/ajg.2009.414. Epub 2009 Jul 14.

PMID:
19603009
15.

Percutaneous radiofrequency ablation of hepatocellular carcinoma: effect of histologic grade on therapeutic results.

Kim SH, Lim HK, Choi D, Lee WJ, Kim SH, Kim MJ, Kim CK, Jeon YH, Lee JM, Rhim H.

AJR Am J Roentgenol. 2006 May;186(5 Suppl):S327-33.

PMID:
16632696
16.

Radiofrequency ablation: technical and clinical long-term outcomes for single hepatocellular carcinoma up to 30 mm.

Brunello F, Cantamessa A, Gaia S, Carucci P, Rolle E, Castiglione A, Ciccone G, Rizzetto M.

Eur J Gastroenterol Hepatol. 2013 Jul;25(7):842-9. doi: 10.1097/MEG.0b013e32835ee5f1.

PMID:
23442417
17.

Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study.

Mazzaferro V, Battiston C, Perrone S, Pulvirenti A, Regalia E, Romito R, Sarli D, Schiavo M, Garbagnati F, Marchianò A, Spreafico C, Camerini T, Mariani L, Miceli R, Andreola S.

Ann Surg. 2004 Nov;240(5):900-9.

18.

Influence of ablative margin on local tumor progression and survival in patients with HCC ≤4 cm after laser ablation.

Francica G, Petrolati A, Di Stasio E, Pacella S, Stasi R, Pacella CM.

Acta Radiol. 2012 May 1;53(4):394-400. doi: 10.1258/ar.2012.110471. Epub 2012 Mar 5.

PMID:
22393158
19.

Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence.

Yang W, Chen MH, Yin SS, Yan K, Gao W, Wang YB, Huo L, Zhang XP, Xing BC.

AJR Am J Roentgenol. 2006 May;186(5 Suppl):S275-83.

PMID:
16632688
20.

[Effect and prognostic analysis of radiofrequency ablation in treating advanced hepatocellular carcinoma].

Wu J, Chen MH, Yan K, Wu W, Yang W.

Zhonghua Yi Xue Za Zhi. 2012 Mar 20;92(11):735-8. Chinese.

PMID:
22781351

Supplemental Content

Support Center